Skip to main content
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 2002 Jun;28(3):147–150. doi: 10.1136/jme.28.3.147

The cultural specifity of research ethics—or why ethical debate in France is different

G Maio 1
PMCID: PMC1733596  PMID: 12042397

Abstract

In the search for a globally binding ethical minimal consensus in dealing with research on human beings the awareness of the cultural specificity of such questions will be of central importance. France provides a good example of such cultural specificities. Three basic structures of French discussion on research ethics can be enumerated: first the particular weight placed on therapeutic benefit, second a particular accentuation on freedom and voluntarism, and third its lesser attention to the aspect of ability to give consent. The weak emphasis on the ability to give consent is rooted as much in the traditionally paternalistically imbued physician-patient relationship as in the French legal system, in which the doctrine of consent is not given the fundamental position of importance found in the Anglo-Saxon countries. As an important Roman country, a different accentuation in the ethical discussion on research on humans can be recognised, a discussion in which for a long time the right of self determination was less of a criterion for decision than the teleology of medical action. It is precisely this aspect of latent cultural influence in ethical convictions which is of decisive importance for future discussion on research on humans.

Full Text

The Full Text of this article is available as a PDF (102.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Weintraub M. The French drug approval process. J Clin Pharmacol. 1982 May-Jun;22(5-6):213–222. doi: 10.1002/j.1552-4604.1982.tb02664.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES